We are live on ! Find out more
TLSI icon

TriSalus Life Sciences
TLSI

72 hedge funds and large institutions have $206M invested in TriSalus Life Sciences in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

80% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 10

6% more funds holding

Funds holding: 68 → 72 (+4)

4.41% more ownership

Funds ownership: 89.24% → 93.66% (+4.4%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less capital invested

Capital invested by funds: $219M → $206M (-$12.4M)

Holders
72
Holders Change
+4
Holders Change %
+5.88%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
18
Reduced
10
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$7.64M
2
Bank of America
Bank of America
North Carolina
+$6.88M
3
UOC
UBS O'Connor
Illinois
+$5.96M
4
HSBC Holdings
HSBC Holdings
United Kingdom
+$4.23M
5
SCM
Shaolin Capital Management
Florida
+$2.03M

Top Sellers

Rank Fund Capital Flow
1
WAM
Weiss Asset Management
Massachusetts
-$11.1M
2
LA
Linden Advisors
New York
-$7.64M
3
GGHC
Gilder Gagnon Howe & Co
New York
-$6.67M
4
Millennium Management
Millennium Management
New York
-$1.41M
5
KC
Kryger Capital
United Kingdom
-$551K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
51
Polar Asset Management Partners
Ontario, Canada
$548K +$547K +55,707 New
LA
52
Linden Advisors
New York
$530K -$7.64M -777,021 -94%
WA
53
Whitebox Advisors
Minnesota
$518K – – –
MC
54
Meteora Capital
Florida
$506K +$505K +51,398 New
TIM
55
Timelo Investment Management
Ontario, Canada
$492K – – –
COPPSERS
56
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$396K – – –
E
57
Ergoteles
New York
$383K – – –
OFG
58
OTA Financial Group
New York
$320K -$44.3K -4,503 -12%
GH
59
GAM Holding
Switzerland
$315K – – –
GCWM
60
Graham Capital Wealth Management
District of Columbia
$281K -$22K -2,240 -7%
UBS Group
61
UBS Group
Switzerland
$244K +$243K +24,694 +20,076%
TCM
62
Tenor Capital Management
New York
$197K – – –
CI Investments Inc
63
CI Investments Inc
Ontario, Canada
$191K – – –
BFM
64
Boothbay Fund Management
New York
$174K +$173K +17,639 New
Geode Capital Management
65
Geode Capital Management
Massachusetts
$169K – – –
Walleye Capital
66
Walleye Capital
New York
$127K – – –
ACA
67
Arena Capital Advisors
California
$42K – – –
Morgan Stanley
68
Morgan Stanley
New York
$40K – – –
PCM
69
Penserra Capital Management
California
$26K -$4.54K -462 -15%
AA
70
Ancora Advisors
Ohio
$21K – – –
MF
71
Magnetar Financial
Illinois
$16.6K – – –
Bank of Montreal
72
Bank of Montreal
Ontario, Canada
$7.65K +$7.64M +777,021 New
SCC
73
Spring Creek Capital
Kansas
– -$4.93M -503,600 Closed
OCAM
74
Owl Creek Asset Management
New York
– -$392K -39,999 Closed
VF
75
Virtu Financial
New York
– -$211K -21,482 Closed
1 2
3
4

TLSI Hedge Fund Activity: Q2 2022 in Review

72 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q2 2022, worth a combined $206M — down 5.7% from $219M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new TLSI positions and 5 closed out — a net gain of 4 holders — while 18 added to existing stakes and 10 trimmed.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $7.64M. The largest seller was Weiss Asset Management, cutting an estimated $11.1M.

  • 72 institutional investors held TriSalus Life Sciences (TLSI) as of Q2 2022, up from 68 in Q1 2022.
  • Funds reported $206M of TriSalus Life Sciences stock for Q2 2022, down 5.7% quarter-over-quarter.
  • 9 funds opened new TriSalus Life Sciences positions in Q2 2022 and 5 closed out, a net change of +4 holders.
  • The largest TriSalus Life Sciences buyer in Q2 2022 was Bank of Montreal, an estimated $7.64M added.
  • The largest TriSalus Life Sciences seller in Q2 2022 was Weiss Asset Management, an estimated $11.1M sold.

Based on aggregated 13F filings for Q2 2022.